Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide Monotherapy Dose-Response in Newly Diagnosed Epilepsy
NCT00056576Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2002
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of zonisamide in epilepsy, sponsored by Eisai Co., Ltd.. Started Feb 2002; status: completed.
02
Drugs
zonisamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00056576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056576.